Rainer Kaiser
@rainerkaiser.bsky.social
Clinician/Scientist at the Dept. of Cardiology @LMU_Uniklinikum investigating mechanisms of platelets and immunity in (cardio)vascular disease.
https://www.lmu-klinikum.de/kardiologie/forschung-und-lehre/grundlagenforschung/ag-kaiser/928efb4b0f6e0b8e?kumA
https://www.lmu-klinikum.de/kardiologie/forschung-und-lehre/grundlagenforschung/ag-kaiser/928efb4b0f6e0b8e?kumA
Read more above - kudos and congratulations to lead author Kami Pekayvaz and senior authors @immunothrombosis.bsky.social and Konstantin Stark!
May 1, 2025 at 6:35 PM
Read more above - kudos and congratulations to lead author Kami Pekayvaz and senior authors @immunothrombosis.bsky.social and Konstantin Stark!
All in all, a great week for our lab filled with translationally relevant new findings - stay tuned for more! 4/4
@immunothrombosis.bsky.social @ash.hematology.org @ekfstiftung.bsky.social @dfg.de @dzhk.de @youngdzhk.bsky.social
@immunothrombosis.bsky.social @ash.hematology.org @ekfstiftung.bsky.social @dfg.de @dzhk.de @youngdzhk.bsky.social
April 5, 2025 at 5:51 AM
All in all, a great week for our lab filled with translationally relevant new findings - stay tuned for more! 4/4
@immunothrombosis.bsky.social @ash.hematology.org @ekfstiftung.bsky.social @dfg.de @dzhk.de @youngdzhk.bsky.social
@immunothrombosis.bsky.social @ash.hematology.org @ekfstiftung.bsky.social @dfg.de @dzhk.de @youngdzhk.bsky.social
Out on the same day, an exciting study from Thomas Thiele's lab at Uni Greifswald describes an intricate mechanism of histone/anti-histone IgG-mediated platelet activation in anti-PF4 negative thrombosis and thrombocytopenia syndrome [email protected] (ashpublications.org/bloodadvance...)
April 5, 2025 at 5:51 AM
Out on the same day, an exciting study from Thomas Thiele's lab at Uni Greifswald describes an intricate mechanism of histone/anti-histone IgG-mediated platelet activation in anti-PF4 negative thrombosis and thrombocytopenia syndrome [email protected] (ashpublications.org/bloodadvance...)
In the same issue, @adriangottsch.bsky.social from the Kobold lab at @lmumuenchen.bsky.social LMU Klinikum München describes a revolutionary and exciting strategy approach to classic Hodgkin lymphoma using single-cell omics and a CD86-based CAR T cell approach.
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
Key PointsCD86 is a promising immunotherapeutic target in cHL, and the CD86–CTLA-4 axis orchestrates an immunosuppressive cHL tumor microenvironment.CD86-t
ashpublications.org
April 5, 2025 at 5:51 AM
In the same issue, @adriangottsch.bsky.social from the Kobold lab at @lmumuenchen.bsky.social LMU Klinikum München describes a revolutionary and exciting strategy approach to classic Hodgkin lymphoma using single-cell omics and a CD86-based CAR T cell approach.
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...